Insurance benefit committee accepted benefits of Olita Tab and Tagrisso Tab on August

Published: 2017-08-08 14:28:02

Updated: 2017-08-08 14:28:02

Hanmi Pharm’s ‘Olita Tab’ and AstraZeneca Korea’s ‘Tagrisso Tab’ were recognized propriety of the health insurance benefits.

The Health Insurance Review & Assessment Service’s Health Insurance Benefit Evaluation Committee decided the health insurance benefits of the 2 drugs after evaluating 5 companies’ 5 products on the 3^rd.

Prefemin Tab, Nucala Inj and Fiblast Spray, however, were not appro...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.